Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_assertion type Assertion NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_head.
- NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_assertion description "[Here, we report the successful application of the TDI assay to detect mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the human leukocyte antigen H (HLA-H) gene, and the receptor tyrosin kinase (RET) protooncogene that are associated with cystic fibrosis, hemochromatosis, and multiple endocrine neoplasia, type 2, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_provenance.
- NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_assertion evidence source_evidence_literature NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_provenance.
- NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_assertion SIO_000772 9380706 NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_provenance.
- NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_assertion wasDerivedFrom befree-20140225 NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_provenance.
- NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_assertion wasGeneratedBy ECO_0000203 NP789144.RAy4t-5Uq9NNz0YwDHMdEm0hxfwYDtp2Glb5Udy-FoPUY130_provenance.